Nexus AG (0FGL.L) Financials
0FGL.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 437.7 million | 154.8 million |
| Sept. 30, 2024 | 415.3 million | 146.1 million |
| June 30, 2024 | 423.6 million | 161.3 million |
| March 31, 2024 | 434.9 million | 171.0 million |
0FGL.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | 19.1 million | ? |
| Sept. 30, 2024 | -1.3 million | ? |
| June 30, 2024 | -273001 | ? |
| March 31, 2024 | 23.6 million | ? |
0FGL.L Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2024 | 11.5 million |
| Sept. 30, 2024 | 7.9 million |
| June 30, 2024 | 5.8 million |
| March 31, 2024 | 6.6 million |
0FGL.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 117.2 million | 15.6 million | 20.9 million |
| Sept. 30, 2024 | 112.1 million | 15.3 million | 20.3 million |
| June 30, 2024 | 13.0 million | 15.4 million | 20.4 million |
| March 31, 2024 | 20.2 million | 15.4 million | 20.2 million |
0FGL.L Shares Outstanding
0FGL.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 4.7 million | - | - | - |
| Sept. 30, 2024 | 1.4 million | - | - | - |
| June 30, 2024 | 2.3 million | - | 5.8 million | - |
| March 31, 2024 | 1.9 million | - | 5.6 million | - |
0FGL.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 70.7 million | 10.9 million |
| Sept. 30, 2024 | 63.1 million | 49.0 million |
| June 30, 2024 | 64.7 million | 51.9 million |
| March 31, 2024 | 63.0 million | 51.3 million |
0FGL.L
Price: €71.70
Dividend Yield: 0.32%
Forward Dividend Yield: 0.32%
Payout Ratio: 19.64%
Dividend Per Share: 0.23 EUR
Earnings Per Share: 1.12 EUR
P/E Ratio: 64.02
Exchange: LSE
Sector: Healthcare
Industry: Medical - Equipment & Services
Market Capitalization: 1.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 14
DGR3: 4.77%
DGR5: 5.03%
DGR10: 5.88%